immune-checkpoint

Documents about immune-checkpoint

• Supplementary Figure S7 from CD4⁺ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy#246365Figshare
• Supplementary Figure S8 from CD4⁺ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy#246366Figshare
• Supplementary Table 1 from CD4⁺ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy#246367Figshare
• Supplementary Table 2 from CD4⁺ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy#246368Figshare
• JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors#882723ClinicalTrials.gov
• Feasibility and Expansion Trial of Transcutaneous Vagus Nerve Stimulation (tVNS) for Immune-Related Fatigue in Patients Receiving Immune Checkpoint Inhibitors#180389ClinicalTrials.gov
• The peripheral immune landscape of human breast cancer#642697Europe PMC
• Exploration of the Predictive Marker and Establishment of Predictive Models of Checkpoint Inhibitor Pneumonitis#839611ClinicalTrials.gov
• Immune Checkpoint Inhibitors in Breast Cancer: Mechanisms, Biomarkers, and Future Therapeutic Strategies.#368100NCBI PubMed Central
• Tumor-intrinsic immune-genetic dynamics identify RNASE1 as an immune-evasion-associated biomarker and predictor of checkpoint blockade response in gastric adenocarcinoma.#371416NCBI PubMed Central
• Molecular innate immune programs of tumor-associated macrophages in immune checkpoint blockade resistance: a staged framework from suppressive circuitry to translational bottlenecks.#476926NCBI PubMed Central
• Immune checkpoint inhibitor rechallenge after immune-related adverse events: a retrospective study from VigiBase update in 2024 looking for emergent safety signals#676816HAL (France)
• Machine learning for Improving Risk Stratification of Hepatocellular Carcinoma (HCC) Patients Treated with Immune Checkpoint Inhibitors (ICIs)#13290DataCite
• Metachronous bilateral renal cancer with immune checkpoint blockade-mediated eradication of bone metastasis: case report#153555HAL (France)
• Treatment of Cancer With Immune Checkpoint Inhibition Therapy Boosted by High Intensity Focused Ultrasound Histotripsy#154652ClinicalTrials.gov
• Urinary Chemokines in the Diagnosis and Monitoring of Immune Checkpoint Inhibitor-Associated Nephritis#184964Dipòsit Digital de la Universitat de Barcelona
• Early ctDNA and Survival in Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors#322420HAL (France)
• Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.#343815ClinicalTrials.gov
• irAE Prediction of Anti-PD-1/L1 in Lung Cancer#346927ClinicalTrials.gov
• Combined therapy strategies of immune checkpoint inhibitors in gynecologic oncology: progress and challenges.#418350NCBI PubMed Central
• Immune checkpoint inhibitor neurotoxicity: long-term outcomes with focus on 1-year neurological sequelae#433385HAL (France)
• Histidine and Immunotherapy Response in Colorectal Cancer#878457ClinicalTrials.gov
• Data Sheet 1_Influence of immune checkpoint inhibitor target and timing on combination treatment with antibody-based β-emitting targeted radionuclide therapy across tumor immunogenicity profiles.pdf#424557Figshare
• An updated review on the role of extracellular vesicles in immune system modulation in breast cancer with special emphasis on immune checkpoint regulators.#418316NCBI PubMed Central
• Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma#872481ClinicalTrials.gov
• Mortality and Cancer Response in Patients with Immune Check Point Inhibitor Associated Uveitis#922293Figshare
• A Pilot Study Testing the Safety and Feasibility of Restorative Microbiota Therapy (RMT) in Patients With Refractory Immune-checkpoint Inhibitor-related Colitis#1008498ClinicalTrials.gov
• Immune checkpoint landscape in CD4⁺ T cells stratifies HIV-infected individuals by clinical progression.#148343NCBI PubMed Central
• Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis#346910ClinicalTrials.gov
• IMmune checkPoint Inhibitor Related gonAdal toxiCiTy in Premenopausal Women and Men With Melanoma#373618ClinicalTrials.gov
• Pharmacovigilance Evaluation of Noninfectious Myocarditis and Pericarditis in Immune Checkpoint Inhibitor Recipients Using FAERS.#404376NCBI PubMed Central
• Investigating the repurposing potential of immune checkpoint inhibition for cancer treatment using Mendelian randomisation#445463Europe PMC
• Inhibitory receptor states, immune homeostasis and the benefit-risk boundary of cancer checkpoint blockade.#476875NCBI PubMed Central
• CT-Based Deep Foundation Model for Predicting Immune Checkpoint Inhibitor-Induced Pneumonitis Risk in Lung Cancer#480179bioRxiv / medRxiv
• The PVR-TIGIT/CD96/CD226 axis: a novel immune checkpoint target in ovarian cancer.#653460NCBI PubMed Central
• Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity Using the Vigilant App#892494ClinicalTrials.gov
• Mechanisms of traditional Chinese medicine in enhancing the efficacy and reducing the toxicity of immune checkpoint inhibitors <i>via</i> regulation of the tumor microenvironment and gut microbiota#243827Europe PMC
• Study of Tuvusertib (M1774) in Combination With DNA Damage Response Inhibitor or Immune Checkpoint Inhibitor (DDRiver Solid Tumors 320)#889901ClinicalTrials.gov
• The role of pathology in immunotherapy and targeted therapy for renal cell carcinoma#268874IRIS
• Observational Study for the Evaluation of Immune-mediated Endocrinological Adverse Events in Patients With Hematological Malignancies and Subjected to Treatment With Immune-checkpoint Inhibitors#474874ClinicalTrials.gov
• Serum Soluble Programmed Death-1 Levels in Adult Immune Thrombocytopenic Purpura Patients and Their Relationship with Disease Duration and Clinical Characteristics#414910HAL (France)
• Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review#6851OpenAlex
• Time-related biases in observational studies : an illustration with COVID-19 vaccination during immune checkpoint inhibitor therapy#223942bioRxiv / medRxiv
• Study Protocol to Characterize Symptom Experience During Immune Checkpoint Inhibitor Therapy for Cutaneous Melanoma.#389015NCBI PubMed Central
• Dynamic peripheral immune monitoring during checkpoint blockade: a framework for interpreting response, toxicity and resistance.#465094NCBI PubMed Central
• Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer#471442ClinicalTrials.gov
• Age and CMV are not associated with clinical or immunological response to immune checkpoint blockade#475690Europe PMC
• Myokine-mediated mechanisms of immune checkpoint inhibitors-associated colorectal injury and repair in rectal cancer.#636341NCBI PubMed Central
• Diagnostic Value of the International Society of Cardio‐Oncology Definition for Suspected Immune Checkpoint Inhibitor–Associated Myocarditis#677198HAL (France)
• Combination of TATE and PD-1 Inhibitor in Liver Cancer#912261ClinicalTrials.gov